A single-dose of the respiratory syncytial virus (RSV) vaccine in older adults showed waning efficacy across three seasons of ...

Zostavax and Shingrix are linked to protection for older adults in multiple studies.

The Advisory Committee on Immunization Practices (ACIP) has voted to expand the recommended use of GSK’s AREXVY (Respiratory ...

A new study is part of a growing body of evidence that vaccination against shingles—and potentially other infections—can be protective against developing dementia. While there is currently no ...

A new global study led by GlaxoSmithKline has found that a single dose of the RSV vaccine Arexvy (RSVPreF3 OA) offers strong ...

Arexvy, already approved in over 60 countries, was supported by trial data showing safety and immune response in the 50–59 age group. GSK said more than 13 million adults in the US fall into this ...

The U.S. Centers for Disease Control and Prevention's panel of outside experts on Wednesday recommended the use of ...

Korea GSK announced on the 10th that it has selected actress Lee Jung-hyun as the official model for its new advertising campaign for the only domestic meningococcal B vaccine 'Bexsero ...

GSK is funding public health organizations working to address US adult immunization gaps and increase community vaccine education, outreach and access These grants are part of GSK’s COiMMUNITY ...

"We encourage people to get the measles vaccine," Kennedy told CBS News chief medical correspondent Dr. Jon LaPook on Tuesday during his Make America Healthy Again tour in Arizona, marking the ...